CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 4 Planned sale Director sold 300,000 shares at an average $46.37 ($13,912,443)
- 4 Open-market sale Chief Accounting Officer sold 1,000 shares at $45.44 ($45,440)
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $45.84 ($3,666,949)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 17,167 shares at $49.00 ($841,183)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $42.63 ($3,410,450)
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 3,500,000 shares at $44.00 ($154,000,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Gift Director gave 20,000 shares (gift)
- 4 Open-market sale Director sold 4,707 shares at an average $44.05 ($207,327)
- 4/A Open-market buy Director bought 1,752 shares at $14.24 ($24,948)
Page 9 of 42 · 834 filings